Type 2 Diabetes Mellitus
📧 Sign up to get email alerts when something new happens for Type 2 Diabetes Mellitus.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2014-05-23Clinical Trial Update: Efficacy and Safety of Liraglutide in Combination With Insulin Therapy Compared to Insulin Alone in Japanese Subjects With Type 2 Diabetes [Phase 3]
Phase 3 trial evaluating liraglutide in combination with insulin versus insulin alone in Japanese adults with type 2 diabetes; results compl…
-
CLINICAL_TRIALS trial_result · 2014-05-23Clinical Trial Update: Evaluation of the Blood Levels of the Drug (Lixisenatide), the Plasma Glucose Levels and Safety in Paediatric and Adult Patients With Type 2 Diabetes [Phase 1]
Phase 1 study evaluating lixisenatide pharmacokinetics (blood levels), plasma glucose effects, and safety in children and adults with Type 2…
-
CLINICAL_TRIALS research · 2014-05-23Clinical Trial Update: Markers and Mechanisms of Vascular Disease in Type II Diabetes
This clinical trial update reports on research into markers and mechanisms of vascular disease in type 2 diabetes and notes that the study h…
-
CLINICAL_TRIALS trial_result · 2014-05-23Clinical Trial Update: Evaluation of the Accuracy of the Abbott Sensor Based Interstitial Glucose Monitoring System
This clinical trial evaluated the accuracy of Abbott's sensor-based interstitial glucose monitoring system in individuals with Type 1 diabet…
-
CLINICAL_TRIALS research · 2014-05-23Clinical Trial Update: Fatty Acid Binding Protein 2 (FABP2) Ancillary Proposal
Clinical trial update for an ancillary FABP2 proposal in Type 2 Diabetes Mellitus; the trial status is completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2014-05-22FDA Approved: JENTADUETO — Supplemental Application (Boehringer Ingelheim Pharmaceuticals, Inc.)
The FDA approved a supplemental application for JENTADUETO, the fixed-dose combination of linagliptin and metformin hydrochloride, submitted…
-
CLINICAL_TRIALS trial_result · 2014-05-22Clinical Trial Update: A Study to Evaluate the Safety, Tolerability, Pharmacokinetics (Explores What the Body Does to the Drug), and Pharmacodynamics (Explores What a Drug Does to the Body) of JNJ-38431055 in Volunteers With Type 2 Diabetes Mellitus [Phase 1]
Phase 1 study of JNJ-38431055 in volunteers with Type 2 diabetes mellitus assessing safety, tolerability, pharmacokinetics, and pharmacodyna…
-
CLINICAL_TRIALS research · 2014-05-21Clinical Trial Update: The Initial Assessment of Daily Insulin Dose in Newly Diagnosed Type 2 Diabetes [NA]
This document provides an update on an ongoing clinical trial evaluating the initial daily insulin dose in adults newly diagnosed with Type …
-
FDA approval · 2014-05-20FDA Approved: WELCHOL — Supplemental Application (Cosette Pharmaceuticals, Inc.)
The FDA approved a supplemental application for Welchol (colesevelam hydrochloride) submitted by Cosette Pharmaceuticals, Inc. The action ap…
-
CLINICAL_TRIALS trial_result · 2014-05-20Clinical Trial Update: A Study to Determine the Efficacy and Safety of Albiglutide as Compared With Liraglutide. [Phase 3]
Phase 3 trial comparing the efficacy and safety of albiglutide versus liraglutide in adults with type 2 diabetes. The study results were pos…
-
CLINICAL_TRIALS trial_result · 2014-05-20Clinical Trial Update: Effects of Legume Consumption on Adiponectin and Inflammatory Markers Among Adults [NA]
This completed clinical trial assessed the effects of legume consumption on adiponectin levels and inflammatory markers in adults with Type …
-
CLINICAL_TRIALS trial_result · 2014-05-19Clinical Trial Update: Efficacy and Safety of Insuman Basal/Comb/Rapid in Patients With Type 2 Diabetes [Phase 4]
A Phase 4 trial assessed the efficacy and safety of Insuman Basal/Comb/Rapid in adults with Type 2 diabetes. The study has completed.
-
CLINICAL_TRIALS trial_result · 2014-05-19Clinical Trial Update: Action in Diabetes and Vascular Disease Preterax and Diamicron MR Controlled Evaluation Post Trial Observational Study
A completed post-trial observational study follow-up of the Preterax and Diamicron MR controlled evaluation in people with type 2 diabetes.
-
CLINICAL_TRIALS trial_result · 2014-05-16Clinical Trial Update: Efficacy and Safety of Albiglutide in Treatment of Type 2 Diabetes [Phase 3]
Phase 3 clinical trial results assess the efficacy and safety of albiglutide for type 2 diabetes; the study completed with results posted in…
-
CLINICAL_TRIALS trial_result · 2014-05-16Clinical Trial Update: A Study of the Efficacy and Safety of Albiglutide in Subjects With Type 2 Diabetes With Renal Impairment. [Phase 3]
The document covers a completed Phase 3 trial evaluating albiglutide in adults with type 2 diabetes and renal impairment. Results were poste…
-
CLINICAL_TRIALS trial_result · 2014-05-16Clinical Trial Update: Albiglutide Glucose Clamp Study in Subjects With Type 2 Diabetes [Phase 2]
Albiglutide was studied in a Phase 2 glucose clamp study in adults with type 2 diabetes. The study has completed and results were posted in …
-
CLINICAL_TRIALS trial_result · 2014-05-14Clinical Trial Update: Efficacy and Safety of CWP-0403 Compared to Sitagliptin in Patients With Type 2 Diabetes Mellitus Insufficiently Controlled With Metformin Alone [Phase 3]
This Phase 3 trial compared the efficacy and safety of CWP-0403 to sitagliptin in adults with type 2 diabetes mellitus inadequately controll…
-
CLINICAL_TRIALS trial_result · 2014-05-14Clinical Trial Update: A Phase III Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes Who Are Not Well Controlled With Diet and Exercise [Phase 3]
A Phase 3 trial update of dapagliflozin (BMS-512148) in adults with type 2 diabetes not adequately controlled by diet and exercise completed…
-
CLINICAL_TRIALS trial_result · 2014-05-14Clinical Trial Update: A Study to Examine the Pharmacokinetics, Tolerability, Safety and Efficacy of Exenatide Once Weekly Suspension [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating the pharmacokinetics, tolerability, safety and efficacy of an exenatide once-weekly suspension in type…
-
CLINICAL_TRIALS trial_result · 2014-05-12Clinical Trial Update: Dietary Supplement of LEHEL for the Patients With Type 2 Diabetes [EARLY_Phase 1]
A Phase 1 (early) trial evaluating the LEHEL dietary supplement in patients with Type 2 diabetes mellitus has completed.
-
CLINICAL_TRIALS research · 2014-05-12Clinical Trial Update: Metronidazole and Amoxicillin for the Treatment of Type 2 Diabetic Subjects With Periodontitis [Phase 4]
An update on a Phase 4 clinical trial evaluating metronidazole and amoxicillin for treating periodontitis in adults with type 2 diabetes mel…
-
CLINICAL_TRIALS trial_result · 2014-05-09Clinical Trial Update: Linagliptin and Metformin Versus Linagliptin in Newly Diagnosed, Untreated Type 2 Diabetes [Phase 4]
Phase 4 trial comparing linagliptin plus metformin versus linagliptin alone in newly diagnosed, untreated type 2 diabetes. Results were post…
-
CLINICAL_TRIALS trial_result · 2014-05-08Clinical Trial Update: Efficacy and Safety Study of MP-513 in Combination With Sulfonylurea in Patients With Type 2 Diabetes [Phase 3]
Phase 3 efficacy and safety results for MP-513 in combination with a sulfonylurea in adults with Type 2 Diabetes.
-
CLINICAL_TRIALS trial_result · 2014-05-08Clinical Trial Update: Efficacy and Safety of the Fixed Dose Combination of Glimepiride+Metformin in Type 2 Diabetic Patients Inadequately Controlled [Phase 3]
Phase 3 trial update evaluating the efficacy and safety of a fixed-dose combination of glimepiride and metformin in patients with inadequate…
-
CLINICAL_TRIALS trial_result · 2014-05-08Clinical Trial Update: The Effect of Spironolactone on Blood Pressure in Type-2 Diabetics With Resistant Hypertension [Phase 3]
This Phase 3 trial evaluated the effect of spironolactone on blood pressure in adults with type 2 diabetes and resistant hypertension. The s…